Use of alpha-adrenergic antagonists for lower urinary tract symptoms is not associated with worsening cognitive function.
Fernanda Gabrigna BertoJ Andrew McClureJeffrey CampbellBlayne WelkPublished in: Neurourology and urodynamics (2024)
Alpha-adrenergic antagonists for LUTS do not appear to increase the risk of cognitive decline, offering reassurance to clinicians and patients.